ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Funding Opportunity: PanCAN Offering $4.1 Million in Research Grants

September 12, 2014

In Brief: NIH Intramural Research Said Needing Better Peer Review, Change In Selecting Counselors

April 23, 1976

BRCA Status Can Guide Ovarian Cancer Treatment

April 25, 2008

HHA “Investigative Memorandum” Revives Controversy Over AIDS Virus, Royalties

July 1, 1994

In Brief: “The Journal” to Mae its Appearance In Jan., With Wittes As Editor; Manuscripts Solicited

October 16, 1987

Study: Lack of Sleep Linked With Agressive Breast Cancers

September 28, 2012